Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder / Joseph Zohar en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 190-195 Título : Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder Tipo de documento: texto impreso Autores: Joseph Zohar, Autor ; Daniela Amital, Autor ; Chanoch Miodownik, Autor Fecha de publicación: 2023 Artículo en la página: pp. 190-195 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Trastornos de combate, Sertralina. Resumen: The efficacy of sertraline in the treatment of civilian posttraumatic stress disorder (PTSD) has been established by two large placebo-controlled trials. The purpose of the current pilot study was to obtain preliminary evidence of the efficacy of sertraline in military veterans suffering from PTSD. Link: ./index.php?lvl=notice_display&id=31085 [artículo] Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder [texto impreso] / Joseph Zohar, Autor ; Daniela Amital, Autor ; Chanoch Miodownik, Autor . - 2023 . - pp. 190-195. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 190-195 Palabras clave: Antidepresivos, Trastornos de combate, Sertralina. Resumen: The efficacy of sertraline in the treatment of civilian posttraumatic stress disorder (PTSD) has been established by two large placebo-controlled trials. The purpose of the current pilot study was to obtain preliminary evidence of the efficacy of sertraline in military veterans suffering from PTSD. Link: ./index.php?lvl=notice_display&id=31085

The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia / Vladimir Lerner en The Journal of Clinical Psychiatry, Año 2013 - Vol.74 - No.12 (Diciembre)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.12 (Diciembre) . - pp. 1224-1232 Título : The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia : a 6-week, randomized, double-blind, placebo-controlled multicenter trial Tipo de documento: texto impreso Autores: Vladimir Lerner, Autor ; Chanoch Miodownik, Autor ; Anatoly Gibel, Autor Fecha de publicación: 2022 Artículo en la página: pp. 1224-1232 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Terapia farmacológica, Trastornos psicóticos, Calidad de vida, Esquizofrenia, Psicología esquizofrénica. Resumen: The limitations of antipsychotic therapy in schizophrenia and schizoaffective disorder led to the investigation of the putative utility of pharmacologic augmentation strategies. The antitumor agent bexarotene via nuclear retinoid X receptor (RXR) activation might modulate numerous metabolic pathways involved in the pathogenesis of schizophrenia and schizoaffective disorder. Link: ./index.php?lvl=notice_display&id=27912 [artículo] The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia : a 6-week, randomized, double-blind, placebo-controlled multicenter trial [texto impreso] / Vladimir Lerner, Autor ; Chanoch Miodownik, Autor ; Anatoly Gibel, Autor . - 2022 . - pp. 1224-1232. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.12 (Diciembre) . - pp. 1224-1232 Palabras clave: Antipsicóticos, Terapia farmacológica, Trastornos psicóticos, Calidad de vida, Esquizofrenia, Psicología esquizofrénica. Resumen: The limitations of antipsychotic therapy in schizophrenia and schizoaffective disorder led to the investigation of the putative utility of pharmacologic augmentation strategies. The antitumor agent bexarotene via nuclear retinoid X receptor (RXR) activation might modulate numerous metabolic pathways involved in the pathogenesis of schizophrenia and schizoaffective disorder. Link: ./index.php?lvl=notice_display&id=27912

L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder / Michael S. Ritsner en The Journal of Clinical Psychiatry, Año 2011 - Vol.72 - No.1 (Enero)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No.1 (Enero) . - pp. 34-42 Título : L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder : an 8-week, randomized, double-blind, placebo-controlled, 2-center study Tipo de documento: texto impreso Autores: Michael S. Ritsner, Autor ; Chanoch Miodownik, Autor ; Yael Ratner, Autor Fecha de publicación: 2022 Artículo en la página: pp. 34-42 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos cognitivos, Terapia farmacológica, Glutamatos, Pruebas neuropsicológicas, Trastornos psicóticos, Esquizofrenia. Resumen: L-theanine is a unique amino acid present almost exclusively in the tea plant. It possesses neuroprotective, mood-enhancing, and relaxation properties. This is a first study designed to evaluate the efficacy and tolerability of L-theanine augmentation of antipsychotic treatment of patients with chronic schizophrenia and schizoaffective disorder. Link: ./index.php?lvl=notice_display&id=27924 [artículo] L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder : an 8-week, randomized, double-blind, placebo-controlled, 2-center study [texto impreso] / Michael S. Ritsner, Autor ; Chanoch Miodownik, Autor ; Yael Ratner, Autor . - 2022 . - pp. 34-42. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No.1 (Enero) . - pp. 34-42 Palabras clave: Trastornos cognitivos, Terapia farmacológica, Glutamatos, Pruebas neuropsicológicas, Trastornos psicóticos, Esquizofrenia. Resumen: L-theanine is a unique amino acid present almost exclusively in the tea plant. It possesses neuroprotective, mood-enhancing, and relaxation properties. This is a first study designed to evaluate the efficacy and tolerability of L-theanine augmentation of antipsychotic treatment of patients with chronic schizophrenia and schizoaffective disorder. Link: ./index.php?lvl=notice_display&id=27924

---

1 (1 - 3 / 3)